Literature DB >> 21073375

Gastric phenotype in children with Helicobacter pylori infection undergoing upper endoscopy.

Wolfgang Hoepler1, Karin Hammer, Johann Hammer.   

Abstract

INTRODUCTION: Helicobacter pylori is a definite risk factor for the development of gastric cancer, especially in the context of corpus-predominant gastritis. The infection is usually acquired in early childhood, implying lifelong exposure to this carcinogen if untreated. Our objective was to analyze the prevalence of H. pylori induced corpus-predominant gastritis in children.
MATERIAL AND METHODS: We analyzed the results of 265 esophagogastroduodenoscopies (EGD) in children performed between February 2006 and August 2008; 34 endoscopies were excluded (24 with follow-up investigations, 5 with incomplete data, 5 adults). H. pylori gastritis was defined by the presence of H. pylori in histology or by a positive rapid urease test. Grade of inflammation was rated according to the updated Sydney Scoring System. Gastritis was classified as corpus-predominant when the degree of chronic inflammation was higher in the corpus than in the antrum and vice versa for antrum-predominant gastritis.
RESULTS: Two hundred thirty-one patients (128 female; mean age ± SEM: 10.5 ± 3.5 years) were analyzed. Eighty-four (36%) were H. pylori positive, 147 (64%) patients were negative for H. pylori. In H. pylori positive patients, 39 (46%) patients had pangastritis (one patient with mucosal atrophy, which is regarded as precancerous lesion), 42 (50%) had antrum-predominant gastritis and 3 (4%) had corpus-predominant gastritis. One female patient (15.6 years old) with severe (grade 3) pangastritis had focal mucosal atrophy in both antrum and corpus, but no patient had intestinal metaplasia.
CONCLUSIONS: Corpus-predominant gastritis develops in H. pylori infected children, while mucosal atrophy and intestinal metaplasia develop later in the course of the infection.

Entities:  

Mesh:

Year:  2010        PMID: 21073375     DOI: 10.3109/00365521.2010.533383

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Authors:  Rodolfo Villarreal-Calderon; Arturo Luévano-González; Mariana Aragón-Flores; Hongtu Zhu; Ying Yuan; Qun Xiang; Benjamin Yan; Kathryn Anne Stoll; Janet V Cross; Kenneth A Iczkowski; Alexander Craig Mackinnon
Journal:  Ann Diagn Pathol       Date:  2014-02-11       Impact factor: 2.090

Review 2.  Interactions between Helicobacter pylori and gastroesophageal reflux disease.

Authors:  Oya Yucel
Journal:  Esophagus       Date:  2018-08-27       Impact factor: 4.230

3.  Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).

Authors:  Song-Ze Ding; Yi-Qi Du; Hong Lu; Wei-Hong Wang; Hong Cheng; Shi-Yao Chen; Min-Hu Chen; Wei-Chang Chen; Ye Chen; Jing-Yuan Fang; Heng-Jun Gao; Ming-Zhou Guo; Ying Han; Xiao-Hua Hou; Fu-Lian Hu; Bo Jiang; Hai-Xing Jiang; Chun-Hui Lan; Jing-Nan Li; Yan Li; Yan-Qing Li; Jie Liu; You-Ming Li; Bin Lyu; You-Yong Lu; Ying-Lei Miao; Yong-Zhan Nie; Jia-Ming Qian; Jian-Qiu Sheng; Cheng-Wei Tang; Fen Wang; Hua-Hong Wang; Jiang-Bin Wang; Jing-Tong Wang; Jun-Ping Wang; Xue-Hong Wang; Kai-Chun Wu; Xing-Zhou Xia; Wei-Fen Xie; Yong Xie; Jian-Ming Xu; Chang-Qing Yang; Gui-Bin Yang; Yuan Yuan; Zhi-Rong Zeng; Bing-Yong Zhang; Gui-Ying Zhang; Guo-Xin Zhang; Jian-Zhong Zhang; Zhen-Yu Zhang; Peng-Yuan Zheng; Yin Zhu; Xiu-Li Zuo; Li-Ya Zhou; Nong-Hua Lyu; Yun-Sheng Yang; Zhao-Shen Li
Journal:  Gut       Date:  2021-11-26       Impact factor: 23.059

4.  Gastric mucosal precancerous lesions in Helicobacter pylori-infected pediatric patients in central China: A single-center, retrospective investigation.

Authors:  Miao Yu; Jing Ma; Xiao-Xia Song; Qiao-Qiao Shao; Xue-Chun Yu; Muhammad Noman Khan; Ya-Bin Qi; Ruo-Bing Hu; Pei-Ru Wei; Wei Xiao; Bai-Ling Jia; Yan-Bo Cheng; Ling-Fei Kong; Chuan-Liang Chen; Song-Ze Ding
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.